Optimization of metabolomics of defined in vitro gut microbial ecosystems

International Journal of Medical Microbiology

Volumn 306, Issue 5, 2016, Pages 280-289

  Wissenbach, Dirk K ^a,f   Oliphant, Kaitlyn ^b   Rolle Kampczyk, Ulrike ^a   Yen, Sandi ^b   Höke, Henrike ^a,c   Baumann, Sven ^a   Haange, Sven B ^a   Verdu, Elena F ^d   Allen Vercoe, Emma ^b   von Bergen, Martin ^a,c,e  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

^e AALBORG UNIVERSITY   (Denmark)

^f JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

1H NMR; Bioreactor; Human gut microbiota; LC MS MS; Metabolic profiling; Metabolomics

Indexed keywords

BIOREACTOR; EX VIVO STUDY; HOST PATHOGEN INTERACTION; HUMAN; IN VITRO STUDY; INTESTINE FLORA; MASS SPECTROMETRY; METABOLIC FLUX ANALYSIS; METABOLOMICS; MICROBIAL COMMUNITY; MICROBIAL ECOSYSTEM; MICROBIOME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SHORT SURVEY; ECOSYSTEM; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PROCEDURES; THEORETICAL MODEL;

BIOREACTORS; ECOSYSTEM; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; METABOLOMICS; MICROBIOTA; MODELS, THEORETICAL;

EID: 84961774618     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2016.03.007     Document Type: Short Survey

References (60)

1. Allen-Vercoe, E., Bringing the gut microbiota into focus through microbial culture: recent progress and future perspective. Curr. Opin. Microbiol. 16 (2013), 625–629.
2. 1H NMR spectroscopy of fecal extracts enables detection of advanced colorectal neoplasia. J. Proteome Res. 14 (2015), 3871–3881.
3. Amoako-Tuffour, Y., Jones, M.L., Shalabi, N., Labbe, A., Vengallatore, S., Prakash, S., Ingestible gastrointestinal sampling devices: state-of-the-art and future directions. Crit. Rev. Biomed. Eng. 42 (2014), 1–15.
4. Baumann, S., Tomm, J., Rockstroh, M., Barthel, J., Krumsiek, J., Otto, W., Jungnickel, H., Potratz, S., Luch, A., Willscher, E., Theis, F., Von Bergen, M., Subtoxic concentrations of benzo[a]pyrene induce metabolic changes and oxidative stress in non-activated and affect the mTOR pathway in activated Jurkat T cells. J. Integr. OMICS, 4, 2014.
5. Berry, D., Stecher, B., Schintlmeister, A., Reichert, J., Brugiroux, S., Wild, B., Wanek, W., Richter, A., Rauch, I., Decker, T., Loy, A., Wagner, M., Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 4720–4725.
6. Berry, D., Mader, E., Lee, T.K., Woebken, D., Wang, Y., Zhu, D., Palatinszky, M., Schintlmeister, A., Schmid, M.C., Hanson, B.T., Shterzer, N., Mizrahi, I., Rauch, I., Decker, T., Bocklitz, T., Popp, J., Gibson, C.M., Fowler, P.W., Huang, W.E., Wagner, M., Tracking heavy water (D2O) incorporation for identifying and sorting active microbial cells. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E194–E203.
7. Bjerrum, J.T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Gunther, U., Nielsen, O.H., Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 11 (2015), 122–133.
8. Davies, J.M., Abreu, M.T., Host-microbe interactions in the small bowel. Curr. Opin. Gastroenterol. 31 (2015), 118–123.
9. Derrien, M., Belzer, C., de Vos, W.M., Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog., 2016.
10. Dumas, M.E., Kinross, J., Nicholson, J.K., Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 146 (2014), 46–62.
11. Fan, P., Li, L., Rezaei, A., Eslamfam, S., Che, D., Ma, X., Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr. Protein Pept. Sci. 16 (2015), 646–654.
12. Flynn, C.R., Albaugh, V.L., Cai, S., Cheung-Flynn, J., Williams, P.E., Brucker, R.M., Bordenstein, S.R., Guo, Y., Wasserman, D.H., Abumrad, N.N., Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat. Commun., 6, 2015, 7715.
13. Fritz, J.V., Desai, M.S., Shah, P., Schneider, J.G., Wilmes, P., From meta-omics to causality: experimental models for human microbiome research. Microbiome, 1, 2013, 14.
14. Ganter, B., Zidek, N., Hewitt, P.R., Muller, D., Vladimirova, A., Pathway analysis tools and toxicogenomics reference databases for risk assessment. Pharmacogenomics 9 (2008), 35–54.
15. Haange, S.B., Oberbach, A., Schlichting, N., Hugenholtz, F., Smidt, H., von Bergen, M., Till, H., Seifert, J., Metaproteome analysis and molecular genetics of rat intestinal microbiota reveals section and localization resolved species distribution and enzymatic functionalities. J. Proteome Res. 11 (2012), 5406–5417.
16. Herberth, G., Offenberg, K., Rolle-Kampczyk, U., Bauer, M., Otto, W., Roder, S., Grutzmann, K., Sack, U., Simon, J.C., Borte, M., von Bergen, M., Lehmann, I., Group, L.S., Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases. J. Allergy Clin. Immunol. 136 (2015), 495–497.
17. Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., Ojima, Y., Tanaka, K., Tanaka, S., Aoshima, K., Oda, Y., Kakazu, Y., Kusano, M., Tohge, T., Matsuda, F., Sawada, Y., Hirai, M.Y., Nakanishi, H., Ikeda, K., Akimoto, N., Maoka, T., Takahashi, H., Ara, T., Sakurai, N., Suzuki, H., Shibata, D., Neumann, S., Iida, T., Funatsu, K., Matsuura, F., Soga, T., Taguchi, R., Saito, K., Nishioka, T., MassBank: a public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 45 (2010), 703–714.
18. Huttenhower, C., Kostic, A.D., Xavier, R.J., Inflammatory bowel disease as a model for translating the microbiome. Immunity 40 (2014), 843–854.
19. Ivanisevic, J., Zhu, Z.J., Plate, L., Tautenhahn, R., Chen, S., O'Brien, P.J., Johnson, C.H., Marletta, M.A., Patti, G.J., Siuzdak, G., Toward ‘omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal. Chem. 85 (2013), 6876–6884.
20. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000), 27–30.
21. Kau, A.L., Ahern, P.P., Griffin, N.W., Goodman, A.L., Gordon, J.I., Human nutrition, the gut microbiome and the immune system. Nature 474 (2011), 327–336.
22. Khan, K.J., Ullman, T.A., Ford, A.C., Abreu, M.T., Abadir, A., Marshall, J.K., Talley, N.J., Moayyedi, P., Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am. J. Gastroenterol. 106 (2011), 661–673.
23. Kleindienst, S., Herbst, F.A., Stagars, M., von Netzer, F., von Bergen, M., Seifert, J., Peplies, J., Amann, R., Musat, F., Lueders, T., Knittel, K., Diverse sulfate-reducing bacteria of the desulfosarcina/desulfococcus clade are the key alkane degraders at marine seeps. ISME J. 8 (2014), 2029–2044.
24. Kortman, G.A., Dutilh, B.E., Maathuis, A.J., Engelke, U.F., Boekhorst, J., Keegan, K.P., Nielsen, F.G., Betley, J., Weir, J.C., Kingsbury, Z., Kluijtmans, L.A., Swinkels, D.W., Venema, K., Tjalsma, H., Microbial metabolism shifts towards an adverse profile with supplementary iron in the TIM-2 in vitro model of the human colon. Front. Microbiol., 6, 2015, 1481.
25. Lamichhane, S., Yde, C.C., Schmedes, M.S., Jensen, H.M., Meier, S., Bertram, H.C., Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Anal. Chem. 87 (2015), 5930–5937.
26. LeBlanc, J.G., Milani, C., de Giori, G.S., Sesma, F., van Sinderen, D., Ventura, M., Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24 (2013), 160–168.
27. Li, H., Limenitakis, J.P., Fuhrer, T., Geuking, M.B., Lawson, M.A., Wyss, M., Brugiroux, S., Keller, I., Macpherson, J.A., Rupp, S., Stolp, B., Stein, J.V., Stecher, B., Sauer, U., McCoy, K.D., Macpherson, A.J., The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun., 6, 2015, 8292.
28. Magnusdottir, S., Ravcheev, D., de Crecy-Lagard, V., Thiele, I., Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front. Genet., 6, 2015, 148.
29. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 599–608.
30. Marozava, S., Roling, W.F., Seifert, J., Kuffner, R., von Bergen, M., Meckenstock, R.U., Physiology of geobacter metallireducens under excess and limitation of electron donors. Part I. Batch cultivation with excess of carbon sources. Syst. Appl. Microbiol. 37 (2014), 277–286.
31. Marozava, S., Roling, W.F., Seifert, J., Kuffner, R., von Bergen, M., Meckenstock, R.U., Physiology of geobacter metallireducens under excess and limitation of electron donors. Part II. Mimicking environmental conditions during cultivation in retentostats. Syst. Appl. Microbiol. 37 (2014), 287–295.
32. McDonald, J.A., Schroeter, K., Fuentes, S., Heikamp-Dejong, I., Khursigara, C.M., de Vos, W.M., Allen-Vercoe, E., Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J. Microbiol. Methods 95 (2013), 167–174.
33. Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., Reyes, J.A., Shah, S.A., LeLeiko, N., Snapper, S.B., Bousvaros, A., Korzenik, J., Sands, B.E., Xavier, R.J., Huttenhower, C., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol., 13, 2012, R79.
34. Natividad, J.M., Pinto-Sanchez, M.I., Galipeau, H.J., Jury, J., Jordana, M., Reinisch, W., Collins, S.M., Bercik, P., Surette, M.G., Allen-Vercoe, E., Verdu, E.F., Ecobiotherapy rich in firmicutes decreases susceptibility to colitis in a humanized gnotobiotic mouse model. Inflamm. Bowel Dis. 21 (2015), 1883–1893.
35. Neufeld, J.D., Wagner, M., Murrell, J.C., Who eats what, where and when? Isotope-labelling experiments are coming of age. ISME J. 1 (2007), 103–110.
36. Rubingh, C.M., Bijlsma, S., Derks, E.P., Bobeldijk, I., Verheij, E.R., Kochhar, S., Smilde, A.K., Assessing the performance of statistical validation tools for megavariate metabolomics data. Metabolomics 2 (2006), 53–61.
37. Scheppach, W., Effects of short chain fatty acids on gut morphology and function. Gut 35 (1994), S35–S38.
38. Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C., Hardt, P.D., Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18 (2010), 190–195.
39. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., Hoyles, L., Nicholson, J.K., Consortium, M.I.-O., Dore, J., Dumas, M.E., Clement, K., Backhed, F., Nielsen, J., Quantifying diet-Induced metabolic changes of the human gut microbiome. Cell Metab. 22 (2015), 320–331.
40. Smith, C.A., O'Maille, G., Want, E.J., Qin, C., Trauger, S.A., Brandon, T.R., Custodio, D.E., Abagyan, R., Siuzdak, G., METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27 (2005), 747–751.
41. Smith, C.A., Want, E.J., O'Maille, G., Abagyan, R., Siuzdak, G., XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78 (2006), 779–787.
42. Sommer, F., Backhed, F., The gut microbiota—masters of host development and physiology. Nat. Rev. Microbiol. 11 (2013), 227–238.
43. Subramanian, S., Blanton, L.V., Frese, S.A., Charbonneau, M., Mills, D.A., Gordon, J.I., Cultivating healthy growth and nutrition through the gut microbiota. Cell 161 (2015), 36–48.
44. Tautenhahn, R., Patti, G.J., Rinehart, D., Siuzdak, G., XCMS online: a web-Based platform to process untargeted metabolomic data. Anal. Chem. 84:June (11) (2012), 5035–5039.
45. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
46. Venema, K., van den Abbeele, P., Experimental models of the gut microbiome. Best practice & research. Clin. Gastroenterol. 27 (2013), 115–126.
47. Walker, A., Pfitzner, B., Neschen, S., Kahle, M., Harir, M., Lucio, M., Moritz, F., Tziotis, D., Witting, M., Rothballer, M., Engel, M., Schmid, M., Endesfelder, D., Klingenspor, M., Rattei, T., Castell, W.Z., de Angelis, M.H., Hartmann, A., Schmitt-Kopplin, P., Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J. 8 (2014), 2380–2396.
48. Walters, W.A., Xu, Z., Knight, R., Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588 (2014), 4223–4233.
49. Wang, M.H., Achkar, J.P., Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr. Opin. Gastroenterol. 31 (2015), 277–282.
50. Wang, W.L., Xu, S.Y., Ren, Z.G., Tao, L., Jiang, J.W., Zheng, S.S., Application of metagenomics in the human gut microbiome. World J. Gastroenterol. 21 (2015), 803–814.
51. Wirth, H., von Bergen, M., Binder, H., Mining SOM expression portraits: feature selection and integrating concepts of molecular function. BioData Min., 5, 2012, 18.
52. Wishart, D.S., Knox, C., Guo, A.C., Eisner, R., Young, N., Gautam, B., Hau, D.D., Psychogios, N., Dong, E., Bouatra, S., Mandal, R., Sinelnikov, I., Xia, J., Jia, L., Cruz, J.A., Lim, E., Sobsey, C.A., Shrivastava, S., Huang, P., Liu, P., Fang, L., Peng, J., Fradette, R., Cheng, D., Tzur, D., Clements, M., Lewis, A., De Souza, A., Zuniga, A., Dawe, M., Xiong, Y., Clive, D., Greiner, R., Nazyrova, A., Shaykhutdinov, R., Li, L., Vogel, H.J., Forsythe, I., HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37 (2009), D603–D610.
53. Xia, J., Wishart, D.S., MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26 (2010), 2342–2344.
54. Xia, J., Sinelnikov, I.V., Han, B., Wishart, D.S., MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Res. 43 (2015), W251–W257.
55. Xie, G., Zhang, S., Zheng, X., Jia, W., Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes. Electrophoresis 34 (2013), 2787–2798.
56. Xiong, W., Abraham, P.E., Li, Z., Pan, C., Hettich, R.L., Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota. Proteomics 15 (2015), 3424–3438.
57. Yen, S., McDonald, J.A., Schroeter, K., Oliphant, K., Sokolenko, S., Blondeel, E.J., Allen-Vercoe, E., Aucoin, M.G., Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. J. Proteome Res. 14 (2015), 1472–1482.
58. Yi, P., Li, L., The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Vet. Microbiol. 157 (2012), 1–7.
59. Zamboni, N., Saghatelian, A., Patti, G.J., Defining the metabolome: size, flux, and regulation. Mol. Cell 58 (2015), 699–706.
60. von Bergen, M., Jehmlich, N., Taubert, M., Vogt, C., Bastida, F., Herbst, F.A., Schmidt, F., Richnow, H.H., Seifert, J., Insights from quantitative metaproteomics and protein-stable isotope probing into microbial ecology. ISME J. 7 (2013), 1877–1885.